Today's Highlights
Premium
An Approval and Works in Progress. See Also: Fishing for Undervalued Biotech Stocks
Approval Of Anthrax Therapeutic Emergent BioSolutions (EBS) : The FDA has approved Anthrasil™ [Anthrax Immune Globulin Intravenous (Human)], also known as AIGIV, for inhalational anthrax in combinati...
P
Prohost Biotech
1 min read
1
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Tags
Comments (0)
Please sign in to join the discussion